000 | 01881 a2200541 4500 | ||
---|---|---|---|
005 | 20250517051829.0 | ||
264 | 0 | _c20160812 | |
008 | 201608s 0 0 eng d | ||
022 | _a1750-192X | ||
024 | 7 |
_a10.2217/epi.15.28 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPaquette, Alison G | |
245 | 0 | 0 |
_aPlacental epigenetic patterning of glucocorticoid response genes is associated with infant neurodevelopment. _h[electronic resource] |
260 |
_bEpigenomics _cAug 2015 |
||
300 |
_a767-79 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a11-beta-Hydroxysteroid Dehydrogenase Type 2 _xgenetics |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCpG Islands _xgenetics |
650 | 0 | 4 | _aDNA Methylation |
650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
650 | 0 | 4 |
_aEpigenomics _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGestational Age |
650 | 0 | 4 |
_aGlucocorticoids _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfant Behavior _xdrug effects |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMaternal Age |
650 | 0 | 4 |
_aNervous System _xdrug effects |
650 | 0 | 4 |
_aPlacenta _xmetabolism |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aReceptors, Glucocorticoid _xgenetics |
650 | 0 | 4 |
_aReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I _xgenetics |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 |
_aTacrolimus Binding Proteins _xgenetics |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aLester, Barry M | |
700 | 1 | _aLesseur, Corina | |
700 | 1 | _aArmstrong, David A | |
700 | 1 | _aGuerin, Dylan J | |
700 | 1 | _aAppleton, Allison A | |
700 | 1 | _aMarsit, Carmen J | |
773 | 0 |
_tEpigenomics _gvol. 7 _gno. 5 _gp. 767-79 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/epi.15.28 _zAvailable from publisher's website |
999 |
_c25235306 _d25235306 |